Stocks - r/Stocks Daily Discussion & Fundamentals Friday Sep 25, 2020 |
- r/Stocks Daily Discussion & Fundamentals Friday Sep 25, 2020
- Cloud gaming battle heats up as Amazon enters the ring to take on Microsoft and Google
- Here is a Market Recap for today Friday, Sept 25. Please enjoy!
- NIO Began Delivery of the EC6 Today
- How do we make a play on patio heaters?
- Big on Cloudfare?
- Morning Market Synopsis - Friday, Sept. 25, 2020
- How would you calculate ROI
- House Democrats prepare new $2.4 trillion stimulus plan
- Wall Street's top stories at midday
- Opinions on Dassault Systèmes SE (DASTY) ? It seems undervalued compared to Autodesk, Inc. (ADSK).
- Catalyst? J&J COVID vaccine induced strong neutralizing antibody
- How will the TDOC/LVGO merger affect stock price?
- Mother gave me (21M) my deceased father's stock certificates from 20 years ago
- Cost per share increased
- Dry ice shortage and COVID vaccine distribution
- Slack (WORK) as an investment
- PayPal vs Square: Which Fintech Stock Is A Better Buy?
- AAPL dropped this month about the same amount it did during the spring COVID crash, where will it go next?
- Some interesting news in the stock market on Thursday ($CVGI, $SAVA, $MCHX)
- Stock Competition Update: 3 months in
- When is an analysts price target prediction fulfilled?
- COMPASS Pathways becomes first psychedelic company to IPO on NASDAQ. With Capital Markets Gaining Momentum, It's Time to Become a Knowledgeable Investor Today. FREE Psychedelic Capital Conference Ticket Included!
- Palantir Expected to Be Valued at Nearly $22 Billion. Start trading around $10
| r/Stocks Daily Discussion & Fundamentals Friday Sep 25, 2020 Posted: 25 Sep 2020 01:06 AM PDT This is the daily discussion, so anything stocks related is fine, but the theme for today is on fundamentals, but if fundamentals aren't your thing then just ignore the theme and/or post your arguments against fundamentals here and not in the current post. Some helpful day to day links, including news:
Most fundamentals are updated every 3 months due to the fact that corporations release earnings reports every quarter, so traders are always speculating at what those earnings will say, and investors may change the size of their holdings based on those reports. Expect a lot of volatility around earnings, but it usually doesn't matter if you're holding long term, but keep in mind the importance of earnings reports because a trend of declining earnings or a decline in some other fundamental will drive the stock down over the long term as well. See the following word cloud and click through for the wiki: If you have a basic question, for example "what is EBITDA," then google "investopedia EBITDA" and click the Investopedia article on it; do this for everything until you have a more in depth question or just want to share what you learned. Useful links:
See our past daily discussions here. Also links for: Technicals Tuesday, Options Trading Thursday, and Fundamentals Friday. [link] [comments]  |
| Cloud gaming battle heats up as Amazon enters the ring to take on Microsoft and Google Posted: 25 Sep 2020 07:01 AM PDT Amazon unveiled Luna, its own cloud gaming service. The move sees Amazon join a battle with Microsoft and Google to dominate the space. But Amazon is taking a slightly different approach — and it's not guaranteed it'll work out. [link] [comments]  |
| Here is a Market Recap for today Friday, Sept 25. Please enjoy! Posted: 25 Sep 2020 01:07 PM PDT PsychoMarket Recap - Friday, September 25, 2020 Stocks were higher today, with the major benchmarks finishing the day an average of 1.5% up. This unexpected rally comes amid a surge of coronavirus cases in the United States and Europe and concerns that more fiscal stimulus will not be passed. The SPY finished After a steady decline from summer peaks through the beginning of September, new COVID-19 cases appear to be on the rise again in the United States. According to data from the New York Times, there have been 41,822 new cases per day in the country over the past week, a 14% increase from the previous 2 weeks. Among the states seeing the largest increases in new cases over the past 14 days are Wisconsin, North Dakota, and South Dakota. In recent weeks, Europe has struggled to contain a surge in the number of coronavirus cases, with many countries reporting a record number of infections. In France 16,069 new case of Covid-19 were reported, a record for the country. The U.K., which recently announced plans to lockdown once again, reported a record 6,634. These numbers are worse than in March, at the beginning of the pandemic. In response to the increasingly precarious situation, European leaders decried the failure of countries to work together to collectively defeat the virus and told the U.N. General Assembly today that ``the time has come for countries to reinvent international cooperation." Throughout the pandemic, European nations have fought internally about access to equipment and vaccines, erected barriers among neighbors to keep out virus infections, and struggled to agree on collective solutions to fight COVID. Today's rally in the stock market reflects the heightened volatility equities have experienced this month, as concerns over the presidential elections, a surge in coronavirus cases, the slowing pace of economic recovery, and the lack of fiscal stimulus pile up. House Democrats are reportedly working on a $2.4 trillion stimulus plan, which would be down from the more than $3 trillion they originally pursued, but a sum still well above the closer to $1 trillion proposal Senate Republicans had suggested they might accept. For their part, monetary officials like Powell and Mnuchin have urged time and again for Congress to pass additional fiscal relief, though the window of opportunity continues to shrink as the November election looms. Eric Rosengren, the President of the Federal Reserve Bank of Boston, told Yahoo Finance that while the central bank could increase asset purchases to try and support the economy, he was not sure it would be "nearly as supportive, for example, as fiscal policy." Taken together, the myriad concerns manifested themselves in a surge in volatility this month, with stocks changing direction from one day to the next and even intraday. Matt Orton, Director and Portfolio Manager at Carillon Tower Advisers said, "We've shot up really, really far. We've just [gone] through a little bit of a corrective process, taking out some of the froth from the really high-flying performers in the information technology space. And right now with an absence of many catalysts as we head into earnings season, we're likely going to continue to move sideways." Highlights
[link] [comments]  |
| NIO Began Delivery of the EC6 Today Posted: 25 Sep 2020 09:05 AM PDT NIO is beginning delivery of their EC6 model today, their 5 seater premium electric SUV. After all the NKLA mess, it's refreshing to be reminded that there are indeed some EV companies out there that are delivering products. Haven't seen this posted yet so figured I'd do it! disclaimer- I do own a little $NIO, albeit, only about 50 shares [link] [comments]  |
| How do we make a play on patio heaters? Posted: 25 Sep 2020 05:21 AM PDT With winter around the corner, restaurants are scrambling to stretch the patio season as far as possible to circumvent COVID restrictions. I've heard from a buddy in the restaurant industry that everyone in the business is buying patio heaters for this reason. In addition, private households are likely also buying these in order to be able to host outdoor gatherings in colder weather. I've noticed that Home Depot has purchasing limits on these products. Given this information, is there a way to make a direct play (rather than a generic play like HD or WMT)? [link] [comments]  |
| Posted: 25 Sep 2020 11:57 AM PDT I'm looking to make a significant investment (5k-10k) on Cloudfare as I have done my research and strongly believe that this company has huge upside in the years to come. What are your thoughts as to where this stock will be in 10 years time? Are there any downsides that come to mind immediately? [link] [comments]  |
| Morning Market Synopsis - Friday, Sept. 25, 2020 Posted: 25 Sep 2020 07:35 AM PDT US equities mostly higher: Dow +0.05%, S&P 500 +0.18%, Nasdaq +0.66%, Russell 2000 +0.85%
Notable Gainers:
Notable Decliners:
09:28:32 AM CDT on 25 Sep '20 [link] [comments]  |
| Posted: 25 Sep 2020 12:15 PM PDT I can't really seem to get the hang of it, there are no decisive answers online. And most of the time the explanation given actually gives you the ROA or ROIC. So which numbers would you use for the ROI in valuing a company. And how would you actually figure out what a companies investments are for that year? My guess is taking R&D costs+purchases in PPE. But after that I can't figure it out [link] [comments]  |
| House Democrats prepare new $2.4 trillion stimulus plan Posted: 24 Sep 2020 03:13 PM PDT "House Democrats are preparing a new, smaller coronavirus relief package expected to cost about $2.4 trillion as they try to forge ahead with talks with the Trump administration, a source familiar with the plans said Thursday. The bill would include enhanced unemployment insurance, direct payments to Americans, Paycheck Protection Program small-business loan funding and aid to airlines, among other provisions, the person said. To reach the price tag, Democrats would chop roughly $1 trillion from their previous proposal for a fifth pandemic aid plan." How do you think the market will react to this? Feels like everyone has been expecting this for months now, curious to see how it will all shake out. [link] [comments]  |
| Wall Street's top stories at midday Posted: 25 Sep 2020 10:44 AM PDT Stocks rising at midday as Democrats work on new stimulus bid The major averages are higher at midday, as the Nasdaq leads the way with a greater than 1% advance. While concern remains over the U.S. elections and disappointment that Washington has not delivered more stimulus, there may be potential for the stimulus talks to resume as reports indicate the Democrats are working on a new proposal. ECONOMIC EVENTS: In the U.S., durable goods orders edged up 0.4% in August, which was less than expected. Data from the Johns Hopkins Whiting School of Engineering shows there are now 32.3M confirmed cases of COVID-19 worldwide, including nearly 7M in the U.S., and 984,278 deaths due to the disease, including about 203,000 in the U.S. TOP NEWS: Shares of Costco (COST) are 2% lower near noon after the company reported quarterly results last night. Morgan Stanley analyst Simeon Gutman, who said the "knock" on the report was weaker flow-through than market expectation, thinks this should prove temporary and sees a rare "buy the dip" opportunity with the stock off its early September high, he told investors following the earnings report as he and several peers raised their price targets for the stock. In M&A news, William Hill (WIMHY) noted press speculation regarding a possible offer for the company and confirmed that it has received separate cash proposals from Apollo Management (APO) and Caesars Entertainment (CZR). "Following an initial written proposal from Apollo on August 27, William Hill received a further proposal from Apollo and proposals from Caesars," the company said. Discussions are ongoing and each of Apollo and Caesars are required, by not later than 5.00 p.m. London time on October 23, to either announce a firm intention to make an offer for William Hill or announce that they do not intend to make an offer, the company added. In COVID-19 news, Novavax announced that it has initiated its first Phase 3 study to evaluate the efficacy, safety and immunogenicity of NVX-CoV2373, Novavax' COVID-19 vaccine candidate. The trial is being conducted in the United Kingdom, or UK, in partnership with the UK Government's Vaccines Taskforce and is expected to enroll and immunize up to 10,000 individuals between 18-84 years of age, with and without relevant comorbidities, over the next four to six weeks. Meanwhile, European governments will pay claims over an agreed upon limit against AstraZeneca (AZN) over unexpected side-effects from its potential COVID-19 vaccine, Reuters reported, citing an EU official. These terms are different than the terms of the agreement with Sanofi (SNY) as AstraZeneca secured the European Union's backing in a confidential agreement which reflects the lower price requested by the drugmaker, the official noted. Reuters reported that U.S. District Judge Carl Nichols said that the White House must either postpone a ban on U.S. app stores offering TikTok for download or file legal documents defending the decision by Friday. The U.S. Commerce Department order banning Apple (AAPL) or Google's (GOOG) app stores from offering TikTok for new downloads is set to occur late Sunday. Oracle (ORCL) and Walmart (WMT) have agreed to take stakes in TikTok Global, a newly created U.S. company that will own most of the app's operations worldwide. MAJOR MOVERS: Among the noteworthy gainers was Colony Capital (CLNY), which rose 9% after it agreed to sell six hospitality portfolios to Highgate for $2.8B. Also higher was MobleIron (MOBL), which jumped 19% after Dealreporter said that the company is in advanced talks to be acquired. Among the notable losers was Fluor (FLR), which slid 4% after it suspended all prior 2020 guidance. Also lower was First Majestic (AG), which fell 7% after it said it is assessing legal options in its dispute with Servicio de Administraction Tributaria. INDEXES: Near midday, the Dow was up 106.44, or 0.40%, to 26,921.88, the Nasdaq was up 128.47, or 1.20%, to 10,800.74, and the S&P 500 was up 20.24, or 0.62%, to 3,266.83. [link] [comments]  |
| Opinions on Dassault Systèmes SE (DASTY) ? It seems undervalued compared to Autodesk, Inc. (ADSK). Posted: 25 Sep 2020 09:24 AM PDT Dassault Systèmes provides software solutions and services worldwide such as SOLIDWORKS design software for 3D design, electrical and printed circuit board design, product data management, simulation, manufacturing, and technical communication and CATIA, an engineering and design software for product 3D computer-aided design. Autodesk offers similar products but from all the reviews I've read online solidworks and catia are better for engineering compared to autodesks autocad and inventor platfroms. DASTY seems to be more diversified though and acquired Medidata Solutions in the past year which is an American technology company that develops and markets software as a service (SaaS) for clinical trials. These include protocol development, clinical site collaboration and management; randomization and trial supply management; capturing patient data through web forms, mobile health (mHealth) devices, laboratory reports, and imaging systems; quality monitor management; safety event capture; and monitoring and business analytics. I can't find much discussion on the topic as Dassault Systemes doesn't seem to be a very popular stock in the US. In my opinion they seem like the better play compared to autodesk as they are targeting the medical field as well which could be incredibly lucrative as more medical companies embrace modernization. [link] [comments]  |
| Catalyst? J&J COVID vaccine induced strong neutralizing antibody Posted: 25 Sep 2020 02:14 PM PDT Johnson & Johnson's Covid-19 Vaccine Produced Immune Response in Earlier-Stage StudyPositive results are basis for J&J's decision to advance the vaccine candidate into a pivotal late-stage trialJohnson & Johnson's JNJexperimental Covid-19 vaccine induced immune responses in most people who received the shot in a small early-stage trial, and also displayed an acceptable safety profile, according to a study posted online Friday.The findings added more detail to J&J's announcement earlier this week that the results from the Phase 1/2 trial were positive, and mean the vaccine, one of the leading candidates in development, has taken another step toward proving whether it works safely.The results supported J&J's decision to start a larger late-stage study of up to 60,000 people that will provide more definitive evidence of whether the vaccine safely protects people from Covid-19, according to the company.The large Phase 3 study could yield initial results by the end of the year or early 2021. If they are positive, the company said it would seek government authorization of emergency use. J&J, of New Brunswick, N.J., started the first human study of its vaccine, code-named Ad26. COV2. S, in July in Belgium and the U.S., with a target of enrolling more than 1,000 adults.Various dose levels and dosing regimens were tested on the study subjects.Detailed interim results from the study were posted on the online preprint server medRxiv. The site publishes medical manuscripts before they are vetted by peer reviewers and published in medical journals.Among the vast majority of certain subgroups of trial subjects, the study said, a single dose of the vaccine induced so-called neutralizing antibodies to the coronavirus when measured in blood samples about four weeks after vaccination.Neutralizing antibodies are agents of the immune system that researchers believe can block the virus and ward off Covid-19.The concentrations of neutralizing antibodies induced by the vaccine were comparable to levels seen in the blood of people who had recovered from Covid-19, the study said. The neutralizing antibody responses among those vaccinated were comparable between younger adults and older adults, it said.The early-stage study didn't, however, show whether these immune responses prevented Covid-19. That will be tested in the new, larger study.Some people in the early-stage study experienced injection-site pain, fever, fatigue, headache and muscle pain after vaccination. Researchers said no one discontinued participation in the trial due to adverse events. [peter.loftus@wsj.com](mailto:peter.loftus@wsj.com) [link] [comments]  |
| How will the TDOC/LVGO merger affect stock price? Posted: 25 Sep 2020 09:34 AM PDT As we know, Teladoc and Livingo health have agreed to merge, with LVGO shareholders receiving .592 shares of TDOC + $11.33 in cash for each whole share. Slightly old news, but still relevant as we near the close of the TDOC/LVGO merger. I'm curious about others' opinions of the merger, as I own significant shares of each company. I was disappointed at first because both companies were killing it until the news broke of the merger. Everything I've read seems mixed. Some believe this merger will create an industry leading Telehealth giant, while others think the growth was based solely off the Pandemic and the need for virtual healthcare outlets. I plan on holding through the merger. When the merger does go through, how will stock price be affected? Will shares become diluted due to the acquisition of LVGO shares? Will the massive amount of debt ($1.9 billion) the combined companies acquired factor in? Any opinions are welcome. [link] [comments]  |
| Mother gave me (21M) my deceased father's stock certificates from 20 years ago Posted: 24 Sep 2020 04:06 PM PDT As the title says my mother just gave me 3 different stock certificates of shares that my now deceased father purchased over 20 years ago, he passed away about 10 years ago. I googled the companies and have only been able to find very minimal information if any at all.
I have no idea where to begin with respect to cashing these out and determining if some of them even exist anymore. I have seen other posts saying to contact a broker and I will have to fill out a form but I'm not sure which brokerages offer this service, I trade options with TastyWorks but have a Charles Schwab account. Also, on two of the certificates there is the name of an old friend of my dads. My mom said that my dad told her he screwed him over with that one so I really don't know as my dad didn't make the best decisions. Any help is greatly appreciated!!! Update: after getting off the phone with Charles Scwab it was determined that sometime Magnaco bought Cota. They went out of business in 2011 and XCL Ltd. went bankrupt in 2008. I can't say I'm not disappointed but oh well. There's one more certificate that my mother needs to find but that one's probably worthless too. Thank you all for being supportive!!! [link] [comments]  |
| Posted: 25 Sep 2020 12:04 PM PDT If I sell a part of a stock at a loss, does Ameritrade increase my cost per to reflect that? Say I buy 2 shares of XXX at 10 and I sell 1 at 5. Would the cost per share of the remaining share be 15? I just saw cost per share for a company that is pretty high and I don't recall buying at that price. But I did still part of it at a loss and the above would explain it if that's what happens [link] [comments]  |
| Dry ice shortage and COVID vaccine distribution Posted: 24 Sep 2020 08:27 PM PDT There is a shortage and need for dry ice in order to store/transport COVID vaccines. There is already a shortage and we are only in the trial phase. How do we capitalize on this demand? I see that McKesson (MCK) is the distributor for the vaccine and will look into them tommorow, but I am more interested in dry ice. Does anyone have any knowledge on companies that might make it or where to start? I've googled around a bit but haven't found much on it yet for a link to US distribution. Looking forward to your ideas! [link] [comments]  |
| Posted: 25 Sep 2020 02:10 PM PDT Sack is a company that has benefited from the change from office to working at home. From the Q2 of Slack "Paid Customer growth — which is the single most important driver of the business over the long term — accelerated in Q2, up 30% year-over-year," said Stewart Butterfield, Chief Executive Officer and Co-Founder at Slack. The total revenue for q2 was Total revenue was $215.9 million a 49 % YOY. In 2021 they are expeditor to make $870 million to $876 million in total revenue. Their net loss for July 2020 was around 61 million for the first 6 months of the year. I expect them to turn a profit next year in Q3 or Q4 based on this growth. Slacks opposition is Facebook and Microsoft. I expect as more and more people work from home more people will use slack as it is superior to Microsoft teams and Facebook messenger. According to the analysts at Yahoo Finance slack will grow between 28% and 38% percent per year. Slack also has a great future based on the fact that the internet continuing to grow and more people using internet communication as many tof things are linked together on a simple and a great product(Slack). Slack is number 10 of ARKK portfolios with a 2.92% of ARKK. If ARKK invests in Slack then they must see something that will disrupt and continue to grow very much. [link] [comments]  |
| PayPal vs Square: Which Fintech Stock Is A Better Buy? Posted: 24 Sep 2020 06:15 PM PDT The COVID-19 pandemic is accelerating digitalization and has led to a spike in online transactions and e-commerce sales. According to PayPal, the penetration of e-commerce as a percentage of retail sales in the first half of 2020 outpaced prior external forecast by 3 to 5 years. Both consumers and merchants are increasingly adopting digital payments as contactless transactions have become increasingly important amid the current crisis. The rapid penetration of digital payments led to double-digital revenue growth in the second quarter for PayPal and Square. Using the TipRanks Stock Comparison tool, we will place these two fintech payment firms alongside each other to assess which stock offers a more compelling investment opportunity. PayPal Holdings (PYPL) PayPal, which was spun off from eBay in 2015, has emerged as the digital payment leader. In the second quarter, PayPal added 21.3 million net new active accounts, reflecting a 137% Y/Y rise and marking the strongest growth in the company's history thanks to a surge in e-commerce and digital payments. As of the end of 2Q, PayPal had 346 million active accounts with over 26 million merchant accounts. The company's 2Q revenue surged 22.2% Y/Y to $5.26 billion. And adjusted EPS rose 49% to $1.07 as the adjusted operating margin expanded 504 basis points to 28.2%. Total Payment Volume or TPV, which indicates payments processed through the PayPal platform, grew about 29% to $222 billion. Venmo, Paypal's mobile payments platform, witnessed a 52% growth in its TPV to $37 billion. Following the strong 2Q momentum, PayPal reinstated its 2020 guidance and in fact, raised it. The company expects revenue growth of 20% and adjusted EPS growth of about 25%. It anticipates adding 70 million net new active accounts this year. To boost its top-line further and promote touchless payments, PayPal launched QR Code technology in 28 markets globally in May. CVS Pharmacy will be the first retail chain to offer its customers the option to use PayPal and Venmo QR codes at checkout in its US stores. The company will also launch Venmo credit card this year. PayPal has also expanded its Visa Direct partnership globally to accelerate real-time access to funds for small businesses, consumers and partners across its platform. This collaboration enables PayPal to extend global white label Visa Direct payout services through PayPal and its Braintree, Hyperwallet and iZettle platforms. On Sept. 22, Mizuho Securities analyst Dan Dolev reiterated a Buy rating for PayPal with a price target of $285 as the Mizuho E-Commerce Tracker showed that unique views across key PayPal partner sites (like Etsy, Groupon and Wayfair) remained strong in July and August and also pointed to potential signs of life in the beleaguered travel category. The Tracker also indicated that PayPal's unique views continued to grow ahead of partner websites in the last two months, reflecting persistent share gains for the checkout button. Overall, the analyst expects strong July and August e-commerce trends coupled with share gains to bode well for the company's second-half TPV. (See PYPL stock analysis on TipRanks) PayPal stock has rallied about 74% year-to-date and could rise further by 17% in the coming months as indicated by the average analyst price target of $219.77. The stock scores a Strong Buy consensus based on 28 Buys, 5 Holds and no Sell ratings. Square (SQ) Payment facilitator Square is growing rapidly as consumers and businesses are migrating online at a faster pace amid the pandemic. From February through August 2020, there was a 13.2 percentage point increase in the share of Square sellers accepting online payments and by August, over 40% of all Square sellers were accepting online payments. Also, by August, more than 7 in 10 Square sellers were accepting contactless payments. The company's Cash App ecosystem delivered $1.2 billion in revenue in the second quarter, reflecting a whopping 361% Y/Y growth. The Cash App had over 30 million monthly transacting active customers in June. Aside from the accelerated digital migration, Cash App also gained from the impact of Fed stimulus, unemployment checks and tax refunds. Second-quarter revenue grew about 64% Y/Y to $1.92 billion. But excluding bitcoin revenue, net revenue of $1.05 billion was flat Y/Y. Meanwhile, 2Q adjusted EPS declined 14.3% to $0.18. The strong growth in Cash App revenue was offset by the 17% decline in the company's core higher-margin Seller business to $723 million. Square's gross payment volume or GPV fell 15% Y/Y to $22.8 billion. The Seller segment was impacted by lower volumes as several businesses were forced to close amid the shelter-in-place orders triggered by the pandemic. However, the company stated that the Sellers business improved with each month in the quarter as restrictions eased and more sellers adapted to the contactless platform. Meanwhile, GPV from online channels grew over 50% and accounted for 25% of the Seller GPV reflecting the rapid adaption of online solutions by the sellers. (See SQ stock analysis on TipRanks) Recently, the company announced two new features called On-Demand Pay for employees and Instant Payments for employers. These new features will further integrate Square's Seller and Cash App ecosystems to offer financial services and simplify payroll. Loop Capital analyst Kenneth Hill has just initiated coverage of Square with a Buy rating and a price target of $169. The analyst sees a great deal of upside ahead in the fintech company, driven by further investment in the business and monetization of the Cash App. Hill also believes that on the Seller side, the SMB network should "hold in well and continue a sustained recovery." The Street has a cautious Moderate Buy consensus for Square with 14 Buys, 12 Holds and 2 Sells. Square stock has risen a stellar 149% year-to-date, so the average analyst price target of $151.77 indicates a possible downside of 2.5% ahead. Bottom line Both PayPal and Square have strong growth prospects in the digital payments world. If we look at the Street's consensus and further upside potential, PayPal stock appears to be a better choice than Square currently. To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a newly launched tool that unites all of TipRanks' equity insights. https://finance.yahoo.com/news/paypal-vs-square-fintech-stock-102007024.html [link] [comments]  |
| Posted: 25 Sep 2020 01:55 PM PDT Earlier this year Apple dropped about 26, along with the market, from a February high around 82 to a COVID-19 low around 56 (adjusted for split). Over the last few weeks, the same thing happened again as it dropped about 28, from a high around 134 at the beginning of September to a low around 106 on the 18th. Where do you see it going next? (Note: I've been long on Apple since early 2000s and will continue to hold though I did sell a little during the recent peak to rebalance) [link] [comments]  |
| Some interesting news in the stock market on Thursday ($CVGI, $SAVA, $MCHX) Posted: 25 Sep 2020 03:23 AM PDT Commercial Vehicle Group was up 6% after OLMA Capital disclosed it had acquired a 6% stake saying the company has huge value and potential for growth. OLMA pointed to the company's resilience during the Covid pandemic and its recent business wins to deliver warehouse automation and provide services to the e-commerce sector. Providing cab equipment, seating, mirrors and wiring for trucks has been a fairly low margin and cyclical business for $CVGI - that's why it currently trades on a forward PE of 10. But the new CEO, Harold Bevis, has some interesting plans. Firstly to optimize profitability in the seating business by shutting down the low margins businesses and moving manufacturing to Mexico. Secondly to develop its electronics subsystems business to support the fast growing Warehouse Automation (WA) market. Management believes that they can quickly target $100mn to $150mn of new business. Significant for a company with trailing revenues of $730mn. However that's a small portion of the fast growing total addressable market for WA currently estimated at $25bn. I have no doubt that the new business will still be competitive, but putting the growth and the focus on profit maximisation together does help to make the current valuation look attractive. Cassava Sciences $SAVA President and CEO Barbier Remi was reported on Thursday to have followed the CFO and other board members and purchased 10,000 shares at an average price of $9.59/share. Investors might want to take note as the purchase follows strong mid-stage trial results for experimental Alzheimer's disease (AD) medication (Sumifilam) and there are currently no other effective AD drugs to compete with it. Now getting a Phase 2b stage drug such as Sumifilam to approval stage is still a long shot (around15% probability on average) so I've been trying to estimate the probability weighted valuation. Starting with a TAM estimate of Alzheimers drugs I found a fool article that said "J.P. Morgan's analysts, among others, have suggested that any disease-modifying AD drug that somehow makes it all the way to market would quickly rack up over $10 billion in sales. And without a major competitor to divvy up the market, that figure could balloon to over $20 billion by 2030. " I'm guessing the only available drug for AD will have healthy margins and a decent valuation around 3x sales ($30bn). Taking that one more stage a 15% chance of $30bn would generate a probability weighted valuation at $4.5bn. That certainly makes the current $242mn market cap look remarkably cheap. Finally Marchex, the call analytics company, jumped 14% yesterday after it was revealed it had increased its tender offer price to buy back its own shares. Investors appear impressed that the company believes it's worth more than the market value and there are good reasons to think that they are right. Marchex $MCHX is a risky microcap but it is the leader in the interesting field of analysing phone calls to generate leads and has won some interesting and large customers such as Firestone. In short it provides analysis of telephone calls using Artificial Inteligence (AI) models in much the same way online software tools seek to analyse your cookies and search history. Notably, in April, it was named the leader in Conversational Intelligence by independent research firm Opus Research. Currently the stock trades at just 1.5x its call analytics revenue despite having a cash-rich balance sheet, cutting-edge technology in a growing software space and significant inside ownership. All in all it looks like a high risk/high reward stock that's probably not for the average punter. But it does look like a potential multibagger. This is is not a recommendation to buy or sell. Stocks are not suitable for everyone. Some of the stocks mentioned are risky small cap and/or highly speculative. Please do your own research. [link] [comments]  |
| Stock Competition Update: 3 months in Posted: 24 Sep 2020 02:26 PM PDT Hey all, 3 months ago, 47 of us picked 5 stocks to go long for a competition, each weighted equally in the portfolio. I decided to do this not really for the competitive side, but to see how we as Redditors do with stock picking. You can see the results here: https://docs.google.com/spreadsheets/d/1Jgur-RZuJcwWujWLAGKSeJ3eqCCuskcf4z1y0XprDUU/edit?usp=sharing "new & improved format" tab shows each participants' picks "leaderboard" tab ranks best performing portfolios* "stock leaderboard" tab ranks best performing tickers* (*the positioning on these lists doesn't update automatically, so don't be alarmed if the order is off) FIRST A NOTE ON DIVIDENDS: I wanted to go through all stocks with dividends and assume reinvestment of dividends to be included in performance. What happened? Well, I didn't do that. It was taking far too long and work/school has been crushing me... no excuses. I should've done it and I didn't. So for stocks with a dividend that has come out in the last 3 months, the results won't be accurate. For that I apologize. TIME FRAME: 6/22 - 9/22
SOME TAKE AWAYS FROM THE DATA
1st place by a long shot: u/Ataraxuh, up 68.82% from 6/22 - 9/22
2nd place: u/kex06, up 50.58% from 6/22 - 9/22
Even though NKLA performed terribly, u/kex06 is still in 2nd place due to picking a couple of big winners 3rd place: u/thejmils, up 48.85% from 6/22 - 9/22
u/thejmils certainly took a different approach and still performed very well. while most of us chose growth/momentum stocks, he/she chose a few leveraged ETFs and the Bank of Montreal TOP 20 PERFORMING STOCKS (I forgot to pull individual prices from 9/22, so percentages are actually for 6/22 - 9/24) NIO +140.24% PENN +103.56% I really had my money on DKNG over PENN. literally TSLA +95.01% unbelievable that TSLA has performed this well LVGO +75.17% NAIL +69.53% PTON +67.00% as a bike owner and investor, I'm very pleased FNGU +62.52% Z +61.24% better than RDFN?? seriously? TAN +57.72% somehow the solar ETF did better than ENPH... shocking to me ENPH +52.35% SQ +49.29% "the bank of the future" VWDRY +46.76% MPNGF +39.75% AMD +38.46% ROKU +37.36% it FINALLY jumped. this is a core holding in my portfolio SE +32.34% DKNG +32.17% JMIA +30.32% maybe the most volatile stock during this time period NVDA +29.61% TWTR +28.89% turns out TWTR isn't such a poor performer? that's certainly the way I've looked at it 10 WORST PERFORMING STOCKS (I forgot to pull individual prices from 9/22, so this list is actually for 6/22 - 9/24) WDI -94.53% turns out fraud is a bad thing? I D E X -73.56% not at all sure what this company does... post got auto removed for including a penny stock thus the spaces between letters. silly rule if you ask me NKLA -72.71% see WDI. RIP Trevor. ETHE -68.62% AMRS - 40.14% IVR -39.73% GAN -36.99% so not all gambling stocks are thriving? AYX -36.07% great company, was severely overvalued. demonstrates what can happen with the high growth names when growth slows down. look out ZM? GTE -35.90% DVAX -35.14% PARTICIPANT LIST u/Ataraxuh u/kex06 u/Golfguy2394 u/thejmils u/moogmonster24 u/PolarBearDntCare u/alkaline119 u/TSLA4LIFE1 u/1foxyboi u/Ari_koda u/Adi_PL u/Thenattylimit u/Seltiel u/rebel2rebel u/airetupal u/CrustyMold u/m4r1vs u/ShinoPrime987 u/icker16 u/johnbeer92 u/PM0804 u/jon43123 u/OneOhFourAM u/skywalkinflacko u/juju102494 u/FlatTry3 u/pattyswags716 u/Theorymeltfool1 u/pescennius u/zachyal u/Keewenaw_Lines u/send_the_gnar u/ShellSwitch u/RemarkableTry9 u/Mr_JerryS u/Waffles46 u/LaPulgaAtomica87 u/trustworthydude u/TimonTheGreat u/WorldTraveler35 u/PaulDesmo u/VisionsDB u/GBAgency u/Shitspear u/mw19090 u/JakeSmithsPhone [link] [comments]  |
| When is an analysts price target prediction fulfilled? Posted: 25 Sep 2020 08:34 AM PDT Some analysts (maybe J.P. Morgan?) had a price target of PTON raised to $100 from some lower target. The other day it hit $100 for a few minutes. Did those analysts succeed in their prediction? When an analyst has a price target, is the target prediction fulfilled if it hits that price even momentarily, or is it supposed to be a price average for some specific amount of time, or something else? [link] [comments]  |
| Posted: 25 Sep 2020 11:37 AM PDT COMPASS Pathways has set a bold new precedent by being the first psychedelic company to IPO on the NASDAQ. Capital Markets are hot right now with steam only picking up further steam in this space. Other psilocybin companies are making a big splash as well--including Cybin Corp! Catch Cybin Corp and other industry leaders, thought experts and psychedelic pioneers at our upcoming Psychedelic Capital event on September 30th! Here's a free ticket to the event: https://www.eventbrite.ca/e/psychedelic-capital-fall-the-gold-standard-for-psychedelic-investment-tickets-119450382309?discount=reddit Hope to see you all on Wednesday! [link] [comments]  |
| Palantir Expected to Be Valued at Nearly $22 Billion. Start trading around $10 Posted: 25 Sep 2020 11:16 AM PDT Probably one of the most hyped listings in awhile. Definitely seems like it could be a good opportunity for a good run up post listing. What's everyone [link] [comments]  |
| You are subscribed to email updates from Stocks - Investing and trading for all. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
No comments:
Post a Comment